Hematochezia refers to the passage of bright red or maroon blood per rectum, typically signaling lower gastrointestinal (GI) bleeding. Although it is often perceived as a benign symptom, hematochezia can reflect life-threatening pathology, especially when associated with hemodynamic instability, substantial blood loss, or advanced comorbidity. Clinically, the key medical task is not merely to identify blood but to localize the bleeding source, estimate severity, and rapidly exclude emergent etiologies.
Pathophysiology and bleeding patterns: Hematochezia usually arises from bleeding distal to the ligament of Treitz, where blood remains relatively oxygenated and appears bright red. However, brisk upper GI bleeding can “overwhelm” gastric and small-bowel transit, producing hematochezia rather than melena. This overlap is why early assessment must incorporate patient stability, volume of bleeding, anticoagulant use, anemia history, and symptom chronology. Mechanistically, bleeding may result from mucosal injury (erosions, ulcers), vascular lesions (angiodysplasia), inflammatory disruption (colitis), malignancy-related friability, or anorectal sources.
Common causes: Distal colonic and rectal processes dominate the differential. Diverticular bleeding is a frequent cause in older adults and can be intermittent and brisk. Angiodysplasia accounts for recurrent bleeding episodes, often in the setting of chronic illness and advanced age. Inflammatory bowel disease (ulcerative colitis) may cause bloody diarrhea and systemic inflammatory signs. Infectious colitis can present with blood, fever, and abdominal cramping. Ischemic colitis typically occurs in patients with vascular risk factors and may present with abdominal pain followed by hematochezia. Malignancy—including colorectal cancer—can cause occult or overt bleeding, often with weight loss, iron-deficiency anemia, or altered bowel habits. Less severe anorectal causes include hemorrhoids and anal fissures, usually associated with pain during defecation (fissure) or painless bright red spotting on toilet paper (hemorrhoids).
Red flags and severity assessment: Immediate evaluation is warranted when bleeding is heavy, persistent, or accompanied by syncope, tachycardia, hypotension, dyspnea, severe weakness, or confusion. The clinician should check orthostatic vitals, perform a focused abdominal and rectal exam (as appropriate), and assess for signs of anemia (pallor) or chronic bleeding. Laboratory evaluation typically includes complete blood count, coagulation studies, electrolytes, renal function, and crossmatch if bleeding is significant. Risk stratification tools (e.g., clinical scoring systems used for GI bleeding) may guide triage, but physiologic stability remains the primary determinant.
Diagnostic approach: Initial management addresses resuscitation and stabilization. If stable, the evaluation proceeds with localization. Colonoscopy is commonly used for diagnosis and potential endoscopic therapy in suspected lower GI bleeding, ideally after appropriate bowel preparation. CT angiography may be considered when bleeding is brisk or intermittent but ongoing, providing rapid localization for potential interventional radiology. If suspicion for upper GI bleeding is present (e.g., melena history, hemodynamic collapse, high-risk ulcer features), upper endoscopy may be necessary even when hematochezia is the presenting symptom. Imaging and endoscopy are chosen based on suspected source, urgency, and patient risk.
Treatment principles: The immediate goals are to stop bleeding, correct physiologic derangements, and prevent complications. For significant bleeding, intravenous fluids, blood transfusion guided by hemoglobin level and clinical status, reversal or adjustment of anticoagulation (when appropriate), and targeted hemostatic therapy via endoscopy are central. Endoscopic options include thermal coagulation, clipping, banding, injection therapy, or hemostatic powders depending on the lesion. Diverticular bleeding may respond to endoscopic hemostasis but can recur; angiodysplasia may require repeat therapy and adjunctive pharmacologic strategies in refractory cases. In inflammatory or infectious etiologies, disease-directed therapy (e.g., corticosteroids for ulcerative colitis flares, antibiotics when indicated for specific pathogens) is required.
Prognosis and follow-up: Outcomes depend on the underlying cause, baseline frailty, comorbid cardiovascular disease, and whether bleeding recurs. Persistent or recurrent hematochezia necessitates definitive investigation for neoplasia or chronic inflammatory pathology. Iron studies and hemoglobin trend monitoring are important to detect occult deficits, and patient counseling should emphasize when to seek emergency care.
Educational takeaway: Hematochezia is a symptom with a broad differential ranging from anorectal sources to colorectal cancer and vascular lesions. Accurate triage requires distinguishing severity, considering brisk upper GI bleeding as a mimic, and pursuing timely diagnostic localization with endoscopy or imaging. Source: [JonnoL32552677 / @JonnoL32552677]
Jonno L: @TheBradSherwood When Vespasian and Titus built the Colosseum in Rome, ca 79AD, it wasn’t for the amusement of violinists poets and and orators. It was to amuse the plebs with blood bravery and derring-do.. #breaking
— @JonnoL32552677 May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
